Hostname: page-component-76fb5796d-vvkck Total loading time: 0 Render date: 2024-04-29T18:38:26.342Z Has data issue: false hasContentIssue false

Medical management of severe obstructive sleep apnoea in two cases during the coronavirus disease 2019 pandemic

Published online by Cambridge University Press:  21 March 2022

H S Gajaweera
Affiliation:
Paediatric Respiratory Department, Southampton Children's Hospital, Southampton, UK
C Griffiths
Affiliation:
Paediatric Respiratory Department, Southampton Children's Hospital, Southampton, UK
L H Everitt
Affiliation:
Paediatric Respiratory Department, Southampton Children's Hospital, Southampton, UK
H J Evans*
Affiliation:
Paediatric Respiratory Department, Southampton Children's Hospital, Southampton, UK
*
Author for correspondence: Dr H J Evans, Paediatric Respiratory Department, Southampton Children's Hospital, Southampton SO16 6YD, UK E-mail: Hazel.Evans@uhs.nhs.uk

Abstract

Objective

Severe paediatric obstructive sleep apnoea in typically developing children with adenotonsillar hypertrophy is primarily managed surgically. Non-emergency ENT surgery was paused early in the coronavirus disease 2019 pandemic and children were offered medical management for obstructive sleep apnoea.

Methods

A service evaluation was performed to assess the impact of continuous positive airway pressure alongside medical management for severe obstructive sleep apnoea.

Results

Over 5 months during 2020, in a tertiary care setting, two children (one boy and one girl), aged 2.7 years and 4.1 years, were offered continuous positive airway pressure and medical treatments for severe obstructive sleep apnoea whilst surgery was paused during the coronavirus disease 2019 pandemic. Both children failed to establish continuous positive airway pressure therapy because of ongoing disturbed sleep on ventilation, and they proceeded to adenotonsillectomy. Sleep-Related Breathing Disorder scale scores improved following surgical intervention.

Conclusion

Continuous positive airway pressure therapy is poorly tolerated in children with severe obstructive sleep apnoea secondary to adenotonsillar hypertrophy. Surgery remains the most appropriate treatment.

Type
Clinical Records
Copyright
Copyright © The Author(s), 2022. Published by Cambridge University Press on behalf of J.L.O. (1984) LIMITED

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Dr H J Evans takes responsibility for the integrity of the content of the paper

References

Whitla, L, Lennon, P. Non-surgical management of obstructive sleep apnoea: a review. Paediatr Int Child Health 2017;37:15CrossRefGoogle ScholarPubMed
Marcus, CL, Moore, RH, Rosen, CL, Giordani, B, Garetz, SL, Taylor, HG et al. ; Childhood Adenotonsillectomy Trial (CHAT). A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med 2013;368:2366–76CrossRefGoogle ScholarPubMed
Fehrm, J, Nerfeldt, P, Browaldh, N, Friberg, D. Effectiveness of adenotonsillectomy vs watchful waiting in young children with mild to moderate obstructive sleep apnea: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg 2020;146:647–54CrossRefGoogle ScholarPubMed
Chervin, RD, Hedger, K, Dillon, JE, Pituch, KJ. Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems. Sleep Med 2000;1:2132CrossRefGoogle ScholarPubMed